LOX and nonpapillary renal cell carcinoma: LOX/LOXL2 overexpression in human clear cell renal cell carcinoma (ccRCC) [31, 32] promoted tumor cell migration and adhesion, as well as matrix stiffness to enhance tumor progression and metastasis [32].